Literature DB >> 3068034

Preclinical toxicology and pharmacology of dimethylacetamide, with clinical notes.

S N Kim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3068034     DOI： 10.3109/03602538808994140

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  5 in total

1.  Oral formulation of a novel antiviral agent, PG301029, in a mixture of gelucire 44/14 and DMA (2:1, wt/wt).

Authors:  Yan He; Jennifer L H Johnson; Samuel H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2005-04-08       Impact factor: 3.246

2.  Biological monitoring of occupational exposure to N,N-dimethylacetamide with identification of a new metabolite.

Authors:  L Perbellini; A Princivalle; M Caivano; R Montagnani
Journal:  Occup Environ Med       Date:  2003-10       Impact factor: 4.402

3.  Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy.

Authors:  H P Bhagwatwar; S Phadungpojna; D S Chow; B S Andersson
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

4.  Dimethylacetamide-induced occupational toxic hepatitis with a short term recurrence: a rare case report.

Authors:  Wei Gong; Xin Liu; Baoli Zhu
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 5.  Toxicant-associated steatohepatitis.

Authors:  Banrida Wahlang; Juliane I Beier; Heather B Clair; Heather J Bellis-Jones; K Cameron Falkner; Craig J McClain; Matt C Cave
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.